Epidemiologic study of major complications in adolescent and adult patients with thalassemia in Northeastern Thailand: the E-SAAN study phase I

References

• Weatherall DJ. The definition and epidemiology of non-transfusion-dependent thalassemia. Blood Rev. 2012;26(Suppl 1):S3–S6. doi: 10.1016/S0268-960X(12)70003-6
   PubMed Web of Science ®Google Scholar
• Taher A, Isma’eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis. 2006;37(1):12–20. doi: 10.1016/j.bcmd.2006.04.005
   PubMed Web of Science ®Google Scholar
• Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989;334(8653):27–30. doi: 10.1016/S0140-6736(89)90264-X
   Web of Science ®Google Scholar
• Borgna-Pignatti C, Cappellini MD, De Stefano P, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40–47. doi: 10.1196/annals.1345.006
   PubMed Web of Science ®Google Scholar
• Aessopos A. Cardiac involvement in thalassemia intermedia: a multicenter study. Blood. 2001;97(11):3411–3416. doi: 10.1182/blood.V97.11.3411
   PubMed Web of Science ®Google Scholar
• Aessopos A, Farmakis D, Deftereos S, et al. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest. 2005;127(5):1523–1530. doi: 10.1378/chest.127.5.1523
   PubMed Web of Science ®Google Scholar
• Aessopos A, Kati M, Farmakis D. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology. Haematologica. 2007;92(5):658–665. doi: 10.3324/haematol.10915
   PubMed Web of Science ®Google Scholar
• Aessopos A, Farmakis D. Pulmonary hypertension in β-thalassemia. Ann N Y Acad Sci. 2005;1054:342–349. doi: 10.1196/annals.1345.041
   PubMed Web of Science ®Google Scholar
• Atichartakarn V, Likittanasombat K, Chuncharunee S, et al. Pulmonary arterial hypertension in previously splenectomized patients with β-thalassemic disorders. Int J Hematol. 2003;78(2):139–145. doi: 10.1007/BF02983382
   PubMed Web of Science ®Google Scholar
• Aessopos A, Stamatelos G, Skoumas V, et al. Pulmonary hypertension and right heart failure in patients with β-thalassemia intermedia. Chest. 1995;107(1):50–53. doi: 10.1378/chest.107.1.50
   PubMed Web of Science ®Google Scholar
• Chueamuangphan N, Wongtheptien W, Nawarawong W, et al. Clinical indicators for pulmonary arterial hypertension in thalassemia. J Med Assoc Thai. 2012;95(1):16–21.
   PubMedGoogle Scholar
• Tantawy AAG, Adly AAM, Mahdy SAR, et al. Spinal cord compression and extramedullary hematopoiesis in young Egyptian β-thalassemia patients. Hemoglobin. 2009;33(6):448–462. doi: 10.3109/03630260903337451
   PubMed Web of Science ®Google Scholar
• Haidar R, Mhaidli H, Taher AT. Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia. Eur Spine J. 2010;19(6):871–878. doi: 10.1007/s00586-010-1357-2
   PubMed Web of Science ®Google Scholar
• Intragumtornchai T, Arjhansiri K, Posayachinda M, et al. Obstructive uropathy due to extramedullary haematopoiesis in β thalassaemia/haemoglobin E. Postgrad Med J. 1993;69(807):75–77. doi: 10.1136/pgmj.69.807.75
   PubMed Web of Science ®Google Scholar
• Aessopos A, Tassiopoulos S, Farmakis D, et al. Extramedullary hematopoiesis-related pleural effusion: the case of β-thalassemia. Ann Thorac Surg. 2006;81(6):2037–2043. doi: 10.1016/j.athoracsur.2006.01.026
   PubMed Web of Science ®Google Scholar
• Jensen CE, Tuck SM, Agnew JE, et al. High incidence of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metab. 1998;11(Suppl 3):975–977.
   PubMed Web of Science ®Google Scholar
• Toumba M, Skordis N. Osteoporosis syndrome in thalassaemia major: an overview. J Osteoporos. 2010: 1–7. doi: 10.4061/2010/537673
   Google Scholar
• Sakran W, Levin C, Kenes Y, et al. Clinical spectrum of serious bacterial infections among splenectomized patients with hemoglobinopathies in Israel: a 37-year follow-up study. Infection. 2012;40(1):35–39. doi: 10.1007/s15010-011-0178-5
   PubMed Web of Science ®Google Scholar
• Rahav G, Volach V, Shapiro M, et al. Severe infections in thalassaemic patients: prevalence and predisposing factors. Br J Haematol. 2006;133(6):667–674. doi: 10.1111/j.1365-2141.2006.06082.x
   PubMed Web of Science ®Google Scholar
• Vento S, Cainelli F, Cesario F. Infections and thalassaemia. Lancet Infect Dis. 2006;6(4):226–233. doi: 10.1016/S1473-3099(06)70437-6
   PubMed Web of Science ®Google Scholar
• Taher AT, Otrock ZK, Uthman I, et al. Thalassemia and hypercoagulability. Blood Rev. 2008;22(5):283–292. doi: 10.1016/j.blre.2008.04.001
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Musallam KM, Poggiali E, et al. Hypercoagulability in non-transfusion-dependent thalassemia. Blood Rev. 2012;26(Suppl 1):S20–S23. doi: 10.1016/S0268-960X(12)70007-3
   PubMed Web of Science ®Google Scholar
• Taher AT, Musallam KM, Karimi M, et al. Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost. 2010;8(10):2152–2158. doi: 10.1111/j.1538-7836.2010.03940.x
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Eleftheriou A, Malaventura C. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the thalassaemia international federation (TIF). Pediatr Endocrinol Rev. 2004;2(Suppl 2):249–255.
   PubMedGoogle Scholar
• Perera NJ, Lau NS, Mathews S, et al. Overview of endocrinopathies associated with β-thalassaemia major. Intern Med J. 2010;40(10):689–696. doi: 10.1111/j.1445-5994.2010.02254.x
   PubMed Web of Science ®Google Scholar
• Taher AT, Musallam KM, El-Beshlawy A, et al. Age-related complications in treatment-naïve patients with thalassaemia intermedia. Br J Haematol. 2010;150(4):486–489.
   PubMed Web of Science ®Google Scholar
• Taher AT, Musallam KM, Karimi M, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010;115(10):1886–1892. doi: 10.1182/blood-2009-09-243154
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Robbiolo L, Bottasso BM, et al. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol. 2000;111(2):467–473. doi: 10.1046/j.1365-2141.2000.02376.x
   PubMed Web of Science ®Google Scholar
• Teawtrakul N, Ungprasert P, Pussadhamma B, et al. Effect of genotype on pulmonary hypertension risk in patients with thalassemia. Eur J Haematol. 2014;92(5):429–434. doi: 10.1111/ejh.12261
   PubMed Web of Science ®Google Scholar
• Teawtrakul N, Jetsrisuparb A, Sirijerachai C, et al. Severe bacterial infections in patients with non-transfusion-dependent thalassemia: prevalence and clinical risk factors. Int J Infect Dis. 2015;39:53–56. doi: 10.1016/j.ijid.2015.09.001
   PubMed Web of Science ®Google Scholar
• Jensen CE, Tuck SM, Old J, et al. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with β-thalassaemia. Eur J Haematol. 1997;59(2):76–81. doi: 10.1111/j.1600-0609.1997.tb00729.x
   PubMed Web of Science ®Google Scholar
• Skordis N, Michaelidou M, Savva SC, et al. The impact of genotype on endocrine complications in thalassaemia major. Eur J Haematol. 2006;77(2):150–156. doi: 10.1111/j.1600-0609.2006.00681.x
   PubMed Web of Science ®Google Scholar
• Fung EB, Harmatz PR, Lee PDK, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol. 2006;135(4):574–582. doi: 10.1111/j.1365-2141.2006.06332.x
   PubMed Web of Science ®Google Scholar
• Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;22(4 Suppl A):6A–13A. doi: 10.1016/0735-1097(93)90455-A
   PubMed Web of Science ®Google Scholar
• Teawtrakul N, Pussadhamma B, Ungprasert P, et al. A risk score for predicting pulmonary hypertension in patients with non-transfusion-dependent thalassemia in northeastern Thailand: the E-SAAN score. Hematology. 2015;20(7):416–421. doi: 10.1179/1607845414Y.0000000211
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81–S90.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Melton LJ, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–1141. doi: 10.1002/jbmr.5650090802
   PubMed Web of Science ®Google Scholar
• Teawtrakul N, Chansung K, Sirijerachai C, et al. The impact and disease burden of thalassemia in Thailand: a population-based study in 2010. J Med Assoc Thai. 2012;95(Suppl 7):S211–S216.
   PubMedGoogle Scholar
• Wang S-C, Lin K-H, Chern JPS, et al. Severe bacterial infection in transfusion-dependent patients with thalassemia major. Clin Infect Dis. 2003;37(7):984–988. doi: 10.1086/378062
   PubMed Web of Science ®Google Scholar
• Musallam KM, Cappellini MD, Daar S, et al. Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study. Haematologica. 2014;99(11):e218–e221. doi: 10.3324/haematol.2013.097220
   PubMed Web of Science ®Google Scholar